HLN
Haleon plc
Price Chart
Latest Quote
$10.10
-0.01 (-0.10%)
Current Price
| Previous Close | $10.11 |
| Open | $10.17 |
| Day High | $10.24 |
| Day Low | $10.03 |
| Volume | 8,672,224 |
Stock Information
Note: Financial values converted from GBP to USD
| Quarterly Dividend / Yield | $0.19 / 1.91% |
| Shares Outstanding | 4.40B |
| Quarterly Dividend Yield | 1.91% |
| Quarterly Dividend | $0.19 |
| Total Debt | $11.61B |
| Cash Equivalents | $1.82B |
| Revenue | $14.84B |
| Net Income | $2.24B |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $44.48B |
| P/E Ratio | 20.61 |
| EPS (TTM) | $0.49 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $52.33B |
| Sales | $14.84B |
| Income | $2.24B |
| Book/sh | $4.99 |
| Cash/sh | $0.31 |
| Employees | 25K |
Financial Ratios
| Quick Ratio | 0.68 |
| Current Ratio | 0.92 |
| Debt/Eq | 52.37 |
| EPS Growth TTM | 86.40% |
Returns & Margins
| ROA | 4.67% |
| ROE | 10.27% |
| Gross Margin | 64.77% |
| Operating Margin | 23.17% |
| Profit Margin | 15.11% |
Ownership
| Insider Ownership | 0.01% |
| Institutional Ownership | 13.28% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 16.61 |
| PEG | 2.59 |
| P/S | 4.03 |
| P/B | 2.02 |
Analyst Data
| Recommendation | buy |
| Target Price | $11.65 |
Technical Indicators
| SMA20 | $9.53 |
| SMA50 | $9.26 |
| SMA200 | $9.64 |
| RSI | 75.90 |
| ATR | 0.1906 |
| Shares Float | 4.44B |
| Short Float | 0.32% |
| Short Ratio | 1.33 |
| Volatility | 0.24 |
| Rel Volume | 0.99 |
Performance History
| Week | +3.48% |
| Month | +11.11% |
| Quarter | +5.32% |
| 6 Months | +2.85% |
| YTD | +2.34% |
| Year | +6.26% |
| 3 Years | +29.83% |
| 10 Years | +47.10% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $10.10 | 8,672,224 |
| 2026-07-16 | $10.11 | 12,670,400 |
| 2026-07-15 | $9.75 | 4,054,200 |
| 2026-07-14 | $9.70 | 4,293,300 |
| 2026-07-13 | $9.86 | 6,312,900 |
| 2026-07-10 | $9.76 | 3,940,700 |
| 2026-07-09 | $9.71 | 8,420,700 |
| 2026-07-08 | $9.75 | 6,532,900 |
| 2026-07-07 | $9.84 | 6,379,000 |
| 2026-07-06 | $9.72 | 7,250,300 |
| 2026-07-02 | $9.82 | 9,190,200 |
| 2026-07-01 | $9.40 | 8,392,900 |
| 2026-06-30 | $9.33 | 7,512,700 |
| 2026-06-29 | $9.33 | 9,131,500 |
| 2026-06-26 | $9.24 | 12,468,800 |
| 2026-06-25 | $9.27 | 7,285,400 |
| 2026-06-24 | $9.23 | 9,769,900 |
| 2026-06-23 | $8.95 | 10,873,900 |
| 2026-06-22 | $8.77 | 12,948,200 |
| 2026-06-18 | $8.96 | 18,834,700 |
About Haleon plc
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
đ° Latest News
Haleon (HLN) Partners with Microsoft (MSFT) to Advance Digital and AI Capabilities
Insider Monkey âĸ 2026-07-12T16:31:10Z
Haleon Signs a Five-Year Agreement With Microsoft (MSFT) to Deploy Agentic AI Across Its Global Operations
Insider Monkey âĸ 2026-07-09T17:23:22Z
From shampoo to cookies, consumer products get an AI makeover
Reuters âĸ 2026-07-06T06:05:54Z
Kyndryl Expands Sovereignty Solutioning with Microsoft (MSFT)
Insider Monkey âĸ 2026-07-02T17:07:57Z
Haleon Just Struck a Five-Year Deal With Microsoft. Here Is What It Means for Haleon Stock.
Barchart âĸ 2026-07-02T16:35:17Z
LCUT vs. HLN: Which Stock Is the Better Value Option?
Zacks âĸ 2026-07-01T15:40:03Z
Powerhouse Energy, Quantum Blockchain, Futura Medical, ATOME, DeFi Development Corp UK
Proactive âĸ 2026-06-29T08:46:01Z
Futura swaps Haleon for Market Performance Group to drive US Eroxon sales - UPDATE
Proactive âĸ 2026-06-29T06:24:00Z
Unilever exploring $4 billion bid for Thorne supplements
Quartz âĸ 2026-06-26T16:05:49Z
Is Haleon plc (HLN) Stock Still a Growth Opportunity After Analyst Downgrade?
Insider Monkey âĸ 2026-06-25T12:41:56Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $5,277,432,655 | $5,890,683,690 | $6,085,748,290 | $5,719,668,151 |
| Cost Of Revenue | $5,277,432,655 | $5,890,683,690 | $6,085,748,290 | $5,719,668,151 |
| Total Revenue | $14,736,729,667 | $15,007,949,624 | $15,100,137,688 | $14,506,927,536 |
| Operating Revenue | $14,736,729,667 | $15,007,949,624 | $15,100,137,688 | $14,506,927,536 |
| Expenses | ||||
| Interest Expense | $463,612,438 | $526,407,207 | $553,128,385 | $371,424,374 |
| Total Expenses | $11,514,155,600 | $12,060,603,690 | $12,433,364,123 | $12,068,620,044 |
| Net Non Operating Interest Income Expense | $-407,497,964 | $-452,923,967 | $-534,423,560 | $-293,932,958 |
| Total Other Finance Cost | $20,040,884 | $13,360,589 | $14,696,648 | $5,344,236 |
| Interest Expense Non Operating | $463,612,438 | $526,407,207 | $553,128,385 | $371,424,374 |
| Operating Expense | $6,236,722,945 | $6,169,920,000 | $6,347,615,834 | $6,348,951,893 |
| Other Operating Expenses | $-16,032,707 | $-176,359,775 | $36,073,590 | $-41,417,826 |
| General And Administrative Expense | $5,830,561,040 | $5,948,134,223 | $5,896,027,926 | $5,989,552,049 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $2,227,210,186 | $1,926,596,934 | $1,401,525,786 | $1,416,222,434 |
| Net Interest Income | $-407,497,964 | $-452,923,967 | $-534,423,560 | $-293,932,958 |
| Interest Income | $76,155,357 | $86,843,828 | $33,401,472 | $82,835,652 |
| Normalized Income | $2,180,274,288 | $1,882,230,685 | $1,372,367,637 | $1,404,210,290 |
| Net Income From Continuing And Discontinued Operation | $2,227,210,186 | $1,926,596,934 | $1,401,525,786 | $1,416,222,434 |
| Total Operating Income As Reported | $3,222,574,067 | $2,947,345,933 | $2,666,773,564 | $2,438,307,492 |
| Net Income Common Stockholders | $2,227,210,186 | $1,926,596,934 | $1,401,525,786 | $1,416,222,434 |
| Net Income | $2,227,210,186 | $1,926,596,934 | $1,401,525,786 | $1,416,222,434 |
| Net Income Including Noncontrolling Interests | $2,244,578,952 | $1,970,686,878 | $1,484,361,438 | $1,495,049,909 |
| Net Income Continuous Operations | $2,244,578,952 | $1,970,686,878 | $1,484,361,438 | $1,495,049,909 |
| Pretax Income | $2,875,198,753 | $2,551,872,499 | $2,175,103,889 | $2,161,743,300 |
| Special Income Charges | $69,475,063 | $-9,352,412 | $148,302,538 | $-277,900,251 |
| Interest Income Non Operating | $76,155,357 | $86,843,828 | $33,401,472 | $82,835,652 |
| Operating Income | $3,222,574,067 | $2,947,345,933 | $2,666,773,564 | $2,438,307,492 |
| Gross Profit | $9,459,297,012 | $9,117,265,934 | $9,014,389,398 | $8,787,259,385 |
| Per Share | ||||
| Diluted EPS | $0.49 | $0.42 | $0.30 | $0.31 |
| Basic EPS | $0.50 | $0.42 | $0.30 | $0.31 |
| Other | ||||
| Tax Effect Of Unusual Items | $13,186,752 | $13,084,284 | $13,595,735 | $5,356,622 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $3,759,669,745 | $3,453,712,256 | $3,098,320,589 | $2,899,247,813 |
| Total Unusual Items | $60,122,650 | $57,450,533 | $42,753,885 | $17,368,766 |
| Total Unusual Items Excluding Goodwill | $60,122,650 | $57,450,533 | $42,753,885 | $17,368,766 |
| Reconciled Depreciation | $480,981,204 | $432,883,084 | $412,842,200 | $383,448,904 |
| EBITDA (Bullshit earnings) | $3,819,792,395 | $3,511,162,789 | $3,141,074,474 | $2,916,616,579 |
| EBIT | $3,338,811,191 | $3,078,279,706 | $2,728,232,274 | $2,533,167,674 |
| Diluted Average Shares | $6,029,633,816 | $6,135,659,025 | $6,201,441,531 | $6,169,251,971 |
| Basic Average Shares | $6,000,240,520 | $6,096,825,740 | $6,147,042,922 | $6,169,251,971 |
| Diluted NI Availto Com Stockholders | $2,227,210,186 | $1,926,596,934 | $1,401,525,786 | $1,416,222,434 |
| Otherunder Preferred Stock Dividend | $0 | $0 | $0 | $0 |
| Minority Interests | $-17,368,766 | $-44,089,944 | $-82,835,652 | $-78,827,475 |
| Tax Provision | $630,619,801 | $581,185,622 | $690,742,451 | $666,693,391 |
| Other Special Charges | $-69,475,063 | $9,352,412 | $-148,302,538 | $277,900,251 |
| Research And Development | $422,194,612 | $398,145,552 | $415,514,318 | $400,817,670 |
| Selling General And Administration | $5,830,561,040 | $5,948,134,223 | $5,896,027,926 | $5,989,552,049 |
Fetched: 2026-07-13
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-12,275,709,173 | $-13,420,711,650 | $-13,693,267,666 | $-16,172,992,984 |
| Total Assets | $43,595,601,907 | $45,846,861,154 | $45,499,485,840 | $46,514,890,604 |
| Total Non Current Assets | $37,516,533,912 | $38,207,276,363 | $39,062,354,059 | $41,091,827,528 |
| Other Non Current Assets | $49,434,179 | $94,860,182 | $152,310,715 | $176,359,775 |
| Non Current Deferred Taxes Assets | $386,121,022 | $368,752,256 | $354,055,608 | $293,932,958 |
| Financial Assets | $12,024,530 | $0 | $86,843,828 | $58,786,592 |
| Goodwill And Other Intangible Assets | $34,220,476,606 | $35,019,439,828 | $35,879,861,760 | $37,992,170,880 |
| Other Intangible Assets | $23,362,325,925 | $24,061,084,730 | $24,767,859,888 | $26,774,620,356 |
| Current Assets | $6,079,067,995 | $7,639,584,790 | $6,437,131,780 | $5,423,063,075 |
| Hedging Assets Current | $104,212,594 | $173,687,657 | $30,729,355 | $66,802,945 |
| Restricted Cash | $85,507,770 | $73,483,240 | $66,802,945 | $104,212,594 |
| Inventory | $1,369,460,372 | $1,589,910,091 | $1,881,170,931 | $1,801,007,397 |
| Other Receivables | $383,448,904 | $422,194,612 | $442,235,496 | $526,407,207 |
| Taxes Receivable | $259,195,427 | $325,998,372 | $352,719,550 | $128,261,654 |
| Accounts Receivable | $2,193,808,714 | $2,121,661,533 | $1,806,351,633 | $1,986,719,584 |
| Allowance For Doubtful Accounts Receivable | $-56,114,474 | $-48,098,120 | $-38,745,708 | $-54,778,415 |
| Gross Accounts Receivable | $2,249,923,188 | $2,169,759,654 | $1,845,097,341 | $2,041,497,999 |
| Cash Cash Equivalents And Short Term Investments | $1,683,434,214 | $2,932,649,286 | $1,328,042,547 | $809,651,693 |
| Cash And Cash Equivalents | $1,683,434,214 | $2,932,649,286 | $1,328,042,547 | $809,651,693 |
| Cash Financial | $1,683,434,214 | $2,932,649,286 | $1,328,042,547 | $809,651,693 |
| Investmentin Financial Assets | - | $109,556,830 | $0 | - |
| Assets Held For Sale Current | - | $0 | $529,079,324 | $0 |
| Prepaid Assets | - | - | - | $141,622,243 |
| Non Current Deferred Assets | - | - | - | - |
| Receivables | - | - | - | - |
| Accrued Interest Receivable | - | - | - | - |
| Loans Receivable | - | - | - | - |
| Cash Equivalents | - | - | - | - |
| Debt | ||||
| Net Debt | $9,607,599,550 | $10,399,882,478 | $11,089,288,870 | $12,923,697,740 |
| Total Debt | $11,468,729,598 | $13,496,867,008 | $12,600,371,486 | $13,948,454,916 |
| Long Term Debt And Capital Lease Obligation | $10,351,784,357 | $11,510,147,424 | $11,723,916,848 | $13,364,597,177 |
| Long Term Debt | $10,238,219,351 | $11,412,615,124 | $11,605,007,605 | $13,208,278,285 |
| Current Debt And Capital Lease Obligation | $1,116,945,240 | $1,986,719,584 | $876,454,638 | $583,857,739 |
| Current Debt | $1,052,814,413 | $1,919,916,639 | $812,323,811 | $525,071,148 |
| Other Current Borrowings | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $21,572,006,999 | $24,170,641,560 | $23,148,556,501 | $24,527,369,286 |
| Total Non Current Liabilities Net Minority Interest | $14,981,228,446 | $16,405,467,233 | $16,949,243,205 | $18,688,791,893 |
| Other Non Current Liabilities | $40,081,767 | $37,409,649 | $70,811,122 | $29,393,296 |
| Derivative Product Liabilities | $45,426,003 | $93,524,123 | $200,408,835 | $233,810,308 |
| Non Current Deferred Taxes Liabilities | $4,304,781,776 | $4,479,805,492 | $4,658,837,384 | $4,811,148,099 |
| Current Liabilities | $6,590,778,554 | $7,765,174,327 | $6,199,313,296 | $5,838,577,393 |
| Payables | $4,920,704,929 | $4,852,565,925 | $4,580,009,909 | $4,561,305,085 |
| Other Payable | $1,754,245,336 | $1,834,408,870 | $1,651,368,800 | $1,783,638,632 |
| Total Tax Payable | $416,850,377 | $382,112,845 | $450,251,849 | $325,998,372 |
| Accounts Payable | $2,749,609,216 | $2,636,044,210 | $2,478,389,260 | $2,451,668,082 |
| Non Current Deferred Liabilities | - | - | - | - |
| Other Current Liabilities | - | - | - | - |
| Current Deferred Liabilities | - | - | - | - |
| Payables And Accrued Expenses | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $21,944,767,432 | $21,598,728,177 | $22,186,594,093 | $21,819,177,896 |
| Total Equity Gross Minority Interest | $22,023,594,908 | $21,676,219,594 | $22,350,929,338 | $21,987,521,317 |
| Stockholders Equity | $21,944,767,432 | $21,598,728,177 | $22,186,594,093 | $21,819,177,896 |
| Retained Earnings | $37,205,232,188 | $36,436,998,321 | $36,706,882,219 | $35,712,854,397 |
| Preferred Securities Outside Stock Equity | $33,401,472 | $33,401,472 | $33,401,472 | - |
| Gains Losses Not Affecting Retained Earnings | - | - | - | - |
| Other Equity Adjustments | - | - | - | - |
| Other | ||||
| Treasury Shares Number | $62,858,977 | - | - | - |
| Ordinary Shares Number | $11,898,012,791 | $12,187,397,155 | $12,337,934,555 | $12,337,934,555 |
| Share Issued | $11,960,871,767 | $12,187,397,155 | $12,337,934,555 | $12,337,934,555 |
| Tangible Book Value | $-12,275,709,173 | $-13,420,711,650 | $-13,693,267,666 | $-16,172,992,984 |
| Invested Capital | $33,235,801,196 | $34,931,259,940 | $34,603,925,510 | $35,552,527,329 |
| Working Capital | $-511,710,559 | $-125,589,537 | $237,818,484 | $-415,514,318 |
| Capital Lease Obligations | $177,695,834 | $164,335,245 | $183,040,069 | $215,105,483 |
| Total Capitalization | $32,182,986,783 | $33,011,343,301 | $33,791,601,699 | $35,027,456,181 |
| Minority Interest | $78,827,475 | $77,491,416 | $164,335,245 | $168,343,421 |
| Treasury Stock | $208,425,188 | $154,982,832 | $0 | - |
| Additional Paid In Capital | $2,672,118 | $1,336,059 | $0 | $0 |
| Capital Stock | $120,245,301 | $121,581,360 | $122,917,419 | $122,917,419 |
| Common Stock | $120,245,301 | $121,581,360 | $122,917,419 | $122,917,419 |
| Non Current Pension And Other Postretirement Benefit Plans | $152,310,715 | $175,023,716 | $209,761,247 | $215,105,483 |
| Long Term Capital Lease Obligation | $113,565,006 | $97,532,300 | $118,909,242 | $156,318,891 |
| Long Term Provisions | $53,442,356 | $76,155,357 | $52,106,297 | $34,737,531 |
| Current Capital Lease Obligation | $64,130,827 | $66,802,945 | $64,130,827 | $58,786,592 |
| Current Provisions | $92,188,064 | $157,654,950 | $173,687,657 | $94,860,182 |
| Defined Pension Benefit | $90,852,005 | $48,098,120 | $48,098,120 | $33,401,472 |
| Other Investments | $89,515,946 | $109,556,830 | - | - |
| Goodwill | $10,858,150,680 | $10,958,355,098 | $11,112,001,871 | $11,217,550,524 |
| Net PPE | $2,668,109,623 | $2,566,569,147 | $2,541,184,028 | $2,537,175,851 |
| Accumulated Depreciation | $-2,089,596,120 | $-1,910,564,227 | $-1,698,130,862 | $-1,621,975,505 |
| Gross PPE | $4,757,705,743 | $4,477,133,374 | $4,239,314,890 | $4,159,151,356 |
| Construction In Progress | $518,390,853 | $451,587,908 | $498,349,970 | $519,726,912 |
| Other Properties | $1,336,059 | - | $1,336,059 | - |
| Machinery Furniture Equipment | $2,709,527,449 | $2,551,872,499 | $2,303,365,544 | $2,225,874,127 |
| Buildings And Improvements | $133,605,890 | $121,581,360 | $140,286,184 | $171,015,539 |
| Land And Improvements | $1,394,845,492 | $1,352,091,607 | $1,295,977,133 | $1,242,534,777 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,036,781,706 | $1,239,862,659 | $1,456,304,201 | $1,340,067,077 |
| Work In Process | $9,352,412 | $34,737,531 | $26,721,178 | $46,762,062 |
| Raw Materials | $323,326,254 | $315,309,900 | $398,145,552 | $414,178,259 |
| Available For Sale Securities | - | $109,556,830 | - | - |
| Employee Benefits | - | - | - | - |
| Current Deferred Revenue | - | - | - | - |
| Current Accrued Expenses | - | - | - | - |
| Dueto Related Parties Current | - | - | - | - |
| Duefrom Related Parties Current | - | - | - | - |
| Other Short Term Investments | - | - | - | - |
Fetched: 2026-07-13
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $2,967,386,817 | $2,649,404,799 | $2,356,807,900 | $2,318,062,192 |
| Operating Activities | ||||
| Operating Cash Flow | $3,519,179,143 | $3,074,271,529 | $2,805,723,690 | $2,756,289,511 |
| Cash Flow From Continuing Operating Activities | - | - | - | - |
| Operating Gains Losses | - | - | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-551,792,326 | $-424,866,730 | $-448,915,790 | $-438,227,319 |
| Investing Cash Flow | $-462,276,379 | $705,439,099 | $-179,031,893 | $-11,735,941,378 |
| Cash Flow From Continuing Investing Activities | - | - | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-873,782,521 | $-827,020,459 | $0 | $0 |
| Financing Cash Flow | $-4,199,233,123 | $-2,053,522,529 | $-2,094,940,355 | $9,233,503,058 |
| Net Other Financing Charges | $-191,056,423 | $-669,365,509 | $-146,966,479 | $484,989,381 |
| Cash Dividends Paid | $-817,668,047 | $-761,553,573 | $-518,390,853 | $-3,583,309,970 |
| Net Common Stock Issuance | $-873,782,521 | $-827,020,459 | $0 | $0 |
| Common Stock Dividend Paid | - | - | $-518,390,853 | $-3,583,309,970 |
| Cash Flow From Continuing Financing Activities | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-1,806,351,633 | $-750,865,102 | $-738,840,572 | $-2,028,137,410 |
| Issuance Of Debt | $61,458,709 | $1,621,975,505 | $0 | $14,701,992,136 |
| End Cash Position | $1,740,884,747 | $2,948,681,992 | $1,328,042,547 | $816,331,988 |
| Beginning Cash Position | $2,948,681,992 | $1,328,042,547 | $816,331,988 | $542,439,913 |
| Effect Of Exchange Rate Changes | $-65,466,886 | $-105,548,653 | $-20,040,884 | $20,040,884 |
| Changes In Cash | $-1,142,330,360 | $1,726,188,099 | $531,751,442 | $253,851,191 |
| Interest Paid Cff | $-476,973,027 | $-480,981,204 | $-539,767,796 | $-217,777,601 |
| Common Stock Payments | $-873,782,521 | $-827,020,459 | $0 | $0 |
| Net Issuance Payments Of Debt | $-1,744,892,923 | $871,110,403 | $-738,840,572 | $12,673,854,725 |
| Net Long Term Debt Issuance | $-1,744,892,923 | $871,110,403 | $-738,840,572 | $12,673,854,725 |
| Long Term Debt Payments | $-1,806,351,633 | $-750,865,102 | $-738,840,572 | $-2,028,137,410 |
| Long Term Debt Issuance | $61,458,709 | $1,621,975,505 | $0 | $14,701,992,136 |
| Interest Received Cfi | $80,163,534 | $100,204,418 | $36,073,590 | $25,385,119 |
| Net Investment Purchase And Sale | $-8,016,353 | $0 | $0 | $935,241,230 |
| Purchase Of Investment | $-8,016,353 | $0 | $0 | - |
| Net Business Purchase And Sale | $17,368,766 | $595,882,269 | $-94,860,182 | $0 |
| Sale Of Business | $17,368,766 | $595,882,269 | $0 | $0 |
| Purchase Of Business | $0 | $0 | $-94,860,182 | $0 |
| Net Intangibles Purchase And Sale | $-121,581,360 | $343,367,137 | $192,392,482 | $16,032,707 |
| Sale Of Intangibles | $0 | $434,219,142 | $328,670,489 | $48,098,120 |
| Purchase Of Intangibles | $-121,581,360 | $-90,852,005 | $-136,278,008 | $-32,065,414 |
| Net PPE Purchase And Sale | $-430,210,966 | $-334,014,725 | $-312,637,783 | $-406,161,906 |
| Purchase Of PPE | $-430,210,966 | $-334,014,725 | $-312,637,783 | $-406,161,906 |
| Taxes Refund Paid | $-586,529,857 | $-792,282,928 | $-594,546,210 | $-432,883,084 |
| Change In Working Capital | $342,031,078 | $275,228,133 | $-142,958,302 | $241,826,661 |
| Change In Other Current Assets | $84,171,711 | $192,392,482 | $-168,343,421 | $228,466,072 |
| Change In Payable | $167,007,362 | $211,097,306 | $149,638,597 | $517,054,794 |
| Change In Inventory | $177,695,834 | $288,588,722 | $-175,023,716 | $-390,129,199 |
| Change In Receivables | $-86,843,828 | $-416,850,377 | $50,770,238 | $-113,565,006 |
| Other Non Cash Items | $384,784,963 | $383,448,904 | $476,973,027 | $288,588,722 |
| Stock Based Compensation | $114,901,065 | $136,278,008 | $101,540,476 | $20,040,884 |
| Deferred Tax | $630,619,801 | $581,185,622 | $690,742,451 | $666,693,391 |
| Depreciation And Amortization | $480,981,204 | $432,883,084 | $412,842,200 | $383,448,904 |
| Amortization Cash Flow | $160,327,068 | $132,269,831 | $144,294,361 | $142,958,302 |
| Depreciation | $320,654,136 | $300,613,252 | $268,547,839 | $240,490,602 |
| Pension And Employee Benefit Expense | $-97,532,300 | $1,336,059 | $93,524,123 | $-57,450,533 |
| Gain Loss On Investment Securities | $-57,450,533 | $-49,434,179 | - | - |
| Gain Loss On Sale Of PPE | $0 | $-9,352,412 | $16,032,707 | $-40,081,767 |
| Gain Loss On Sale Of Business | $0 | $-161,663,127 | $0 | $0 |
| Net Income From Continuing Operations | $2,244,578,952 | $1,970,686,878 | $1,484,361,438 | $1,495,049,909 |
| Sale Of Investment | - | $0 | $0 | $935,241,230 |
| Sale Of PPE | - | - | $0 | $0 |
| Change In Other Working Capital | - | - | - | - |
| Change In Payables And Accrued Expense | - | - | - | - |
| Change In Account Payable | - | - | - | - |
| Changes In Account Receivables | - | - | - | - |
| Asset Impairment Charge | - | - | - | - |
| Deferred Income Tax | - | - | - | - |
| Depreciation Amortization Depletion | - | - | - | - |
| Amortization Of Intangibles | - | - | - | - |
Fetched: 2026-07-13